Business Development
Innocoll is actively seeking to establish strategic partnerships with pharmaceutical and biotechnology companies that are interested in localized drug delivery and surgical implantable products. Partnership opportunities include:
- Out-license of Innocoll's internally funded development pipeline products. For more information on these opportunities, please visit our Development Products page.
- Co-development partnerships with pharmaceutical and biotechnology companies that are interested in using the CollaRx® and LiquiColl® technologies to:
- Create novel line extensions of existing brands.
- Develop NMEs and proprietary drugs where localized delivery is necessary or desirable.
For additional information about our product and technology opportunities, please contact us at: business-development@innocollinc.com